4//SEC Filing
Kim Dong 4
Accession 0001437749-24-029036
CIK 0001668243other
Filed
Sep 11, 8:00 PM ET
Accepted
Sep 12, 1:50 PM ET
Size
6.6 KB
Accession
0001437749-24-029036
Insider Transaction Report
Form 4
Kim Dong
Chief Financial Officer
Transactions
- Exercise/Conversion
Ordinary Shares
2024-09-09+2,500→ 37,753 total - Exercise/Conversion
Restricted Stock Units
2024-09-09−2,500→ 5,000 total→ Ordinary Shares (2,500 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.
- [F2]The reporting person was granted RSUs on September 7, 2023 representing 7,500 ordinary shares. The RSUs will vest in three equal annual installments from September 7, 2024.
Documents
Issuer
UroGen Pharma Ltd.
CIK 0001668243
Entity typeother
Related Parties
1- filerCIK 0001920163
Filing Metadata
- Form type
- 4
- Filed
- Sep 11, 8:00 PM ET
- Accepted
- Sep 12, 1:50 PM ET
- Size
- 6.6 KB